Zealand Pharma Announces Financial Results for the First Half of 2023
Company announcement - No. 28 / 2023...…
88,025€
0,95%
Echtzeit-Aktienkurs ZEALAND PHARMA A/S DK 1
Bid:
Ask:
Nachrichten zur ZEALAND PHARMA A/S DK 1 Aktie
Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
Press Release – No. 9 / 2023...…
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
Company announcement – No. 27 / 2023...…
Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism
Press release – No. 8 / 2023...…
Total number of shares and voting rights in Zealand Pharma at June 30, 2023
Company announcement – No. 26 / 2023...…
Zealand Pharma Submits Marketing Authorization Application To EMA For Dasiglucagon
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Zealand Pharma A/S (ZEAL) has submitted a Marketing Authorization Application to the European Medicines Agency for dasiglucagon…
Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency
Press release – No. 7 / 2023...…
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
Press release – No. 6 / 2023...…
Adipositas-Mittel von Boehringer wirkt wohl besser als gedacht
Pharma - Das Abnehm-Medikament von Boehringer Ingelheim und der dänischen Biotechfirma Zealand Pharma überrascht mit positiven Studienresultaten....…
Zealand, Boehringer tout higher weight-loss drug efficacy in update
...By Ludwig Burger
FRANKFURT, June 23 (Reuters) - Zealand Pharma...
at Boehringer Ingelheim, told Reuters.
The partners are also eyeing better......…
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)
Press Release No. 5 / 2023...…
Zealand Pharma to Participate in Upcoming Healthcare Conferences
Press release – No. 4 / 2023...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 23 / 2023...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 21 / 2023...…
FACTBOX-Drugmakers bulk up with bets on weight-loss treatments
...May 12 (Reuters) - Zealand Pharma and partner
Boehringer Ingelheim......…
Zealand Pharma Announces Financial Results for the First Quarter of 2023
Company announcement - No. 20 / 2023...…
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight...…
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
Press Release– No. 3 / 2023...…
Total number of shares and voting rights in Zealand Pharma at April 28, 2023
Company announcement – No. 18 / 2023...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 17 / 2023...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 16 / 2023...…
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
Press release – No. 2 / 2023...…
Zealand Pharma completes registration of capital increase
Company announcement – No. 14 / 2023...…
Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen
Company announcement – No. 13 / 2023...…
Total number of shares and voting rights in Zealand Pharma at March 31, 2023
Company announcement – No. 12 / 2023...…
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion
Company announcement – No. 11 / 2023...…
Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares
Company announcement – No. 10 / 2023...…
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement – No. 8 / 2023...…
Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396
Company announcement – No. 7 / 2023...…
Zealand Pharma Expects to Recover All Deposits Held at SVB on Monday
Zealand Pharma Expects to Recover All Deposits Held at SVB on Monday...…
Zealand Pharma expects recovery of DKK 162.6M from Silicon Valley Bank
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zealand Pharma Expects to Recover All Its SVB Deposits
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-Zealand Pharma expects to recover all deposits from SVB
...(Adds amount, detail)
COPENHAGEN, March 13 (Reuters) - Danish drug......…
Zealand Pharma expects to recover deposits from SVB
...COPENHAGEN, March 13 (Reuters) - Danish drug developer
Zealand Pharma......…
Zealand Pharma Provides Update on Silicon Valley Bank Closure
Company announcement – No. 6 / 2023...…
Zealand Pharma Provides Statement on Silicon Valley Bank Closure
Company announcement – No. 5 / 2023...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 4 / 2023...…
Correction: Zealand Pharma convenes its Annual General Meeting 2023
Correction: Company Announcement – No. 2 / 2023...…
Correction: Zealand Pharma Announces Full Year Results for 2022
Company announcement – No. 1 / 2023...…
Zealand Pharma GAAP EPS of -DKK 20.90, revenue of DKK 104M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zealand Pharma convenes its Annual General Meeting 2023
Company Announcement – No. 2 / 2023...…
Zealand Pharma Announces Full Year Results for 2022
Company announcement – No. 1 / 2023...…
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
Press release – No. 1 / 2023...…
Total number of shares and voting rights in Zealand Pharma at December 30, 2022
Company announcement – No. 58 / 2022...…
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement – No. 57 / 2022...…
Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program
Company announcement – No. 55/ 2022...…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 56/ 2022...…
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
Company announcement – No. 54 / 2022...…
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement – No. 53 / 2022...…
Zealand Pharma reports nine-month results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…